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ABSTRACT
The relationship between protein synthesis and commitment to terminal erythroid
differentiation by dimethylsulfoxide-treated murine erythroleukemia (MEL) cells
has been studied. Treatment with cycloheximide blocks the commitment of MEL
cells. The effects of cycloheximide are completely reversible, however. Treatment
of MEL cells before commitment delays commitment for a period of time equal
to the length of inhibitor treatment. Puromycin exerts a similar effect on the
commitment of MEL cells. These results indicate that there is a continuous
requirement for protein synthesis before the commitment event.
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The analysis ofdevelopmental programs in eukar-
yotic organisms has been limited by two consid-
erations: (a) the difficulty in identifying discrete
steps in a specific program, and (b) the difficulty
in establishing the molecular basis for such steps
when they can be identified. The murine erythro-
leukemia (MEL) cell system has attracted much
interest because it offers a model system in which
both these issues can be approached.
Erythroid differentiation in the mouse is one of
the few developmental systems in which the be-
havior of individual cells during a differentiation
program has been analyzed. This analysis has been
possible because individual erythroid precursor
cells can be cloned and induced to differentiate in
vitro in semi-solid media (11). On the basis of this
approach, Axelrad and co-workers were able to
show that erythroid precursors with varying pro-
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liferative capacity could be identified and charac-
terized within a single organ. A limitation of this
analysis has been that normal precursor cells can-
not be obtained as a homogeneous population.
The presence of heterogeneous cell types in the
population under analysis makes the identification
of discrete developmental events difficult at both
the molecular and cellular levels. Use of the MEL
cell system alleviates this difficulty. Permanent
lines of cells resembling nonhemoglobinized pro-
erythroblasts can be obtained from mice infected
with the Friend leukemia virus (1, 18, 19). These
cell lines can be cloned with an efficiency ap-
proaching 100% using plasma clot cultures (6-8).
When exposed to dimethylsulfoxide (DMSO) or
a variety of other chemical agents, these cells will
undergo a differentiation program which in many
aspects resembles very closely the normal eryth-
roid differentiation program (7, 8). In particular,
heme and globin are synthesized in quantity (1,
18); spectrin, an erythrocyte membrane protein, is
synthesized in increased amounts (4); and a variety
715of changes in enzyme levels characteristic of nor-
mal erythroid differentiation is observed as well
(19).
Analysis of the differentiation of MEL cells at
the clonal level has suggested the following con-
clusions: (a) A coordinated differentiation pro-
gram is initiated in each cell that becomes com-
mitted to erythroid differentiation. The character-
istics of this program include expression of high
levels of heme and globin as well as the limitation
of proliferative capacity to four additional cell
generations (7, 8). (b) A latent period of at least 9
h after addition of inducer is usually observed
before a significant number ofcells becomes com-
mitted. Cells that have become committed no
longer require the presence of inducer to execute
the differentiation program. The kinetics of com-
mitment of individual cells are consistent with a
stochastic model for the commitment event. The
proportion of cells that become committedin each
cell generation is a function of the concentration
of inducer: exposure of cellsto a higher concentra-
tion of inducer results in a higher proportion of
committed cells in each cell generation (7, 8).
The identification of a specific reprogramming
step that initiates a coordinated biochemical pro-
gram raises the issue "What is themolecular basis
for the commitment process?" One approach to
this issue has been the use of metabolic inhibitors
to identify themacromolecular processesnecessary
for the execution of a specific step in a develop-
mental process (13, 21). Previous studies in the
MEL cell system that have employed metabolic
inhibitors have failed to clearly define therequire-
ments for specific macromolecular synthesis at
different stages of the differentiation program (9,
10, 12). The major technical limitation of these
studies has been that only the final end products
of the differentiation program have been quanti-
tated rather than the reprogramming decision it-
self. In thepresentstudy, we have approached this
problem in a direct manner. As a prototype for
further inhibitor studies, we present a detailed
analysis of the effects of the inhibitor cyclohexi-
mide on MEL cells undergoing the commitment
process. On thebasisof theseexperiments, specific
conclusions about the macromolecular synthesis
requirements for commitment have been made.
MATERIALS AND METHODS
Cell Lines and Culture Conditions
Cell line 745 was originally obtained from Dr. C.
Friend. 745-PC-4 is a subclone of this cell line. All
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cultures were maintained in a medium (22) lacking
nucleosides and supplemented with 13% fetal calfserum
(Grand Island Biological Co., Grand Island, N. Y.). Cell
density was kept between 1 x 10' and 5 x 1f5/ml to
maintain continuous logarithmic growth. Cell counts
were performedwith an automatic cell counter (Coulter
Countermodel ZBI, Coulter Electronics, Hialeah, Fla.).
Plasma culture was performed as described by Mc-
Cleod et al. (11) and Gusella et al. (7). Briefly, 100-200
cells were plated in 0.1-mlclotsin microtiter wells (Lin-
bro Scientific Co., Hamden, Conn.) that had been steri-
lized by ultraviolet radiation. The clots were incubated
at 37'C in ahumidified 5% COz atmosphere. Clots were
transferred to microscope slides after90-100 h ofculture,
dehydrated with filter paper, fixed in glutaraldehyde,
stained in benzidine, counterstained with hematoxylin,
and covered with permount (FisherScientific Co., Pitts-
burgh, Pa.) and a cover slip. Scoring of colony type was
performed at x 100.
Radioactive Labeling ofProtein
5 x 10'MELcells/ml were seeded in liquid culturein
the presence of 1 .5% DMSO. Cells were grown for22 h,
at whichtime they were centrifuged and resuspended in
a medium lacking leucine at adensity of 2.0 x 10'cells/
ml. Theculturewasthen divided intoseveral subcultures,
to each of which was added [3H]leucine (sp act = 110
Ci/mM) to a final concentration of 25 pCi/ml. At the
appropriate times, a 100-pl aliquot wastaken from each
culture and added to 1 ml of 0.1 N NaOH. Thesamples
were heated at 37'C for 20 min, then were precipitated
by the addition of 1 ml of cold 10% TCA. Samples were
chilled on ice for 15 min, then collected by filtration
undervacuum onto 24-mm glassfiber filters (Whatman
GF/C)andwashed with 5% TCA. Thefilterswere dried
and counted in a Beckman LS-330 liquid scintillation
counter (Beckman Instruments, Inc., Fullerton, Calif.).
Chemicals
Cycloheximide and emetine were obtained from
Sigma Chemical Co. (St. Louis, Mo.). Puromycin was
obtained from ICN Nutritional Biochemicals (Cleve-
land, Ohio). Puromycin and emetine were kindly pro-
videdby Dr. SheldonPenman. ['H]leucine was obtained
from NewEnglandNuclear(Boston, Mass.).
All inhibitors were made as 1 mg/ml stocks in a
medium supplemented with 13% fetal calf serum, and
filter sterilized using amillex disposable filter unit (Mil-
lipore Corp., Bedford, Mass.) with a 0.45-,um filter.
RESULTS
Rationale
In this manuscript we have focused on the re-
quirement for protein synthesis in the MEL cell
system both before the commitment event and at
the time of the commitment event itself. The basicprotocol that we have employed involves the in-
duction of differentiation in MEL cells with
DMSO followed by exposure of the cells to an
inhibitor of protein synthesis for a portion of the
induction period. If events leading to commitment
do notrequire proteinsynthesis, then an inhibitor-
treated culture and its control should show iden-
tical kinetics of commitment to the differentiation
program. If, however, protein synthesis is essential
for any stage of the differentiation program, then
treatment of the cells with a reversible inhibitor
will delay their progress through the program by
an amount of time equal to or greater than the
period of treatment with inhibitor.
Cycloheximide is an Effective and Reversible
Inhibitor of Protein Synthesis in DMSO-
Treated MEL Cells
Before initiating experiments on the effects of
cycloheximide on the commitment to differentia-
tion, we determined the extent of the inhibition of
protein synthesis by cycloheximide on DMSO-
treated MEL cells and the degree to which this
inhibition was reversible. MEL cells were grown
in the presence of 1.5% DMSO for 22 h, and then
a series of parallel cultures were treated with cy-
cloheximide at various doses while the DMSO
concentration was maintained at 1.5%. Incorpo-
ration of ['H]leucine into TCA-precipitable mate-
rial was followed over a 6-h period. At all doses of
cycloheximide, a linear-incorporation rate was ob-
served (correlation coefficients ranged from (0.819
to 0.996). The relative rate of incorporation at
each dose of cycloheximide is shown in Table I.
The highest concentrations ofcycloheximide used,
5 and 0.5 pg/ml, inhibited the rate of protein
synthesis by -95 and -87%, respectively, of the
value for an untreated control culture. A cyclohex-
imide dose of 0.05 itg/ml, on the other hand,
inhibited the rate of protein synthesis by -50%.
The lowest cycloheximide concentration em-
ployed, 0.005 p.g/ml, was found to inhibit the rate
ofproteinsynthesis by ~130 10 ofthe control culture.
Removal of DMSO-treated cultures from thedrug
resulted in a rapid and significant reversal of the
inhibition of protein synthesis. Cultures treated
with cycloheximide for 6 h, then washed free of
the drug, recover very rapidly in their ability to
incorporate ['H]leucine. As shown in Table I, cul-
turesreleased from cycloheximide block ranged in
their rate of protein synthesis from 71 to 100% of
the control value.
Cell Growth
TABLE I
Effect of Cycloheximide on the Rate of
Incorporation of13Hjleucine
Rate of incorpora-
￿
Rate of incorpora-
tion of ['H]leucine
￿
tion of ['"N)leucine
1 x 10r' MEL cells/ml were grown in liquid culture in
the presence of 1.5% DMSO for 22 h. Cells were resus-
pended at adensity of 2 x 105/ml in Ix medium lacking
leucine. DMSO was added to each culture to a final
concentration of 1.5%, and 50 Al of a serial dilution of
cycloheximide in Ix medium + 13% fetal calfserum was
added to give the appropriate final concentration of the
drug. Finally, allcultures were pulsed with 25 ttCi/ml of
['H]leucine. Cultures were maintained in cycloheximide
for6h, at which time cells were centrifuged, washed one
time in fresh a- medium lacking leucine, then resus-
pended in leucine-free a- medium at -2 x 105 cells/ml.
DMSO wasreadded to each culture to afinal concentra-
tion of 1.5%, and allcultures were repulsed with 25 ACi/
ml of ['H]leucine. At 0 h, and at hourly intervals there-
after, aliquots were removed from each culture for de-
termination of acid-precipitable material as dscribed in
Materials and Methods.
* Correlation coefficients appear in parentheses.
Effect of Cycloheximide Treatment on
To determine the degree to which the rate of
cell growth was affected by cycloheximide treat-
ment, we performedtheexperiments shownin Fig.
1. Thecell number in cultures treated with various
dosesofcycloheximide over a 12-h period is shown
in panelA. A controlculture exhibited a doubling
time of -11 h. Aculture treated with 5 x 10-3 tLg/
ml of cycloheximide showed a doubling time of
13 h, slightly greater than that for the control
culture. Growth of a culture treated with 5 x 10-2
ttg/ml ofcycloheximide wasseverely limited, how-
ever. A doubling time of more than 24 h was
observed for this culture. Treatment with 0.5 ttg/
ml of cycloheximide led to complete inhibition of
cell growth. No increase in cell number was ob-
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Effect of cycloheximide treatment on the
rate of growth of MEL cells. Panel A: MEL cells were
grown in liquid culture in the presence of 1.5% DMSO
for 12 h. The cells were then subcultured and growth
continued in the presence of 1 .5% DMSO alone (O);
1.5% DMSO + 0.005 Ag/ml cycloheximide ("); 1 .5%
DMSO + 0.05 lag/ml cycloheximide (q; 1 .5% DMSO
+0.5 wg/ml cycloheximide (/); or 1 .5% DMSO + 5 wg/
ml of cycloheximide (A). At the times indicated, a 1-ml
aliquot of cells was removed from each culture and the
cell density determined using an automatic cell counter.
Panel B: MEL cells were grown in liquid culture for 12
h in the presence of 1.5% DMSO. The cells were then
subcultured and growth continued in the presence of
either 1 .5% DMSO alone or 1 .5% DMSO +various doses
of cycloheximide. After 12 h of treatment with inhibitor,
cycloheximide wasremovedandcell growth was contin-
ued in the presence of 1 .5% DMSO. At the times indi-
cated, cell density was determined as described above.
served over a 12-h period. Treatment with 5 Feg/
ml of cycloheximide also inhibited cell growth
completely, and in fact a slight decrease in cell
number was observed over a 12-h period. This
suggests that exposure to 5 ltg/ml ofcycloheximide
for this period produces some cytotoxic effects.
The growth rates of cultures treated with these
concentrations of cycloheximide for a 12-h period
were compared immediately after removal of cy-
cloheximide, as shown in panel B. When cyclo-
heximide was removed, all cultures (except the
culture treated with 5 ttg/ml of cycloheximide)
immediately returned to a normal doubling time
of 11 h. These results are consistent with the view
that treatment of MEL cells with cycloheximide
foraperiod of 12 h at alldoses up to and including
0.5 Ag/ml does not directly affect cell viability. A
dose of 5 gg/ml of cycloheximide does lead to a
reduction in cell division rate when the inhibitor
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is removed, suggesting that a proportion of the
cells lose viability during the drug treatment pe-
riod. Subsequent experiments involving a mea-
surement of the plating efficiency of cyclohexi-
mide-treated cells confirmed this point. As shown
in Table II, plating efficiencies of 87% or greater
were observed for cultures treated with 1.5%
DMSO plus 0.05 or 0.5 lag/ml of cycloheximide
during a 12-h exposure period. Cells treated with
5 Fig/ml of cycloheximide, on the other hand,
showed a significant reduction in plating effi-
ciency. After 12 h of treatment with 5 !rg/ml of
cycloheximide, the plating efficiency was reduced
to 72%. These results suggest that, at cyclohexi-
mide concentrations up to and including 0.5 Ag/
ml, cells did not suffer irreversible cytotoxic dam-
age as a result of inhibitor treatment, and plate
with an efficiency essentially equivalent to that of
a control culture. Cells treated with 5 lag/ml of
inhibitor, on the otherhand, showed a progressive
loss of plating efficiency, hence cell viability, as
the exposure time to the drug was lengthened.
TABLE II
Effect ofCycloheximide Treatment on the Plating
Efficiency ofMEL Cells in Plasma Culture
MEL cells were grownin liquid culture in the presence
of 1 .5% DMSO for 21 h. Thecells were then subcultured
and growth continued in the presence of 1.5% DMSO
alone or 1.5%DMSO plus either 0.05 lag/ml, 0.5 lug/ml,
or 5 lug/ml of cycloheximide. At 3, 6, and 12 h after the
addition of cycloheximide, an aliquot of cells was re-
moved from each culture and plated in plasma culture
in the absence of DMSO or cycloheximide. Approx. 200
cells were plated per clot. After 96 h of incubation, the
cells were harvested and the number of colonies was
determined as has been described. A minimum of 200
colonies was scored at each time point.
Treatment
Exposure to
cyclohexi-
mide
h
Plating ef-
ciency
1 .5% DMSO - 94
1.5% DMSO + 0.05 lug/ml 3 96
cycloheximide 6 100
12 89
1 .5% DMSO + 0.5 lug/ml 3 100
cycloheximide 6 94
12 87
1 .5% DMSO + 5 wg/ml cy- 3 83
cloheximide 6 76
12 72Pretreatment ofMEL Cells with
Cycloheximide has no Effect on Induction of
the Differentiation Program
Commitment of MELcells is measured by clon-
ing DMSO-treated cells in the absence of either
inducer or inhibitor in the plasma culture system.
The assay for commitment which we have devel-
oped (7) reflects the commitment potential of a
cell at thetime at which the cell was removed from
liquid and plated in plasma clot. The colony phe-
notype observed after 90-100 h of plasma culture
is a measure of the commitment of an individual
cell after plating.
An uncommitted cell gives rise to an undiffer-
entiated colony that will be large (>32 cells) and
unstained with benzidine. A committed cell gives
rise to a differentiated colony. Such a colony is
small (<32 cells) and stains bright orange with
benzidine, a reagent specific for heme, a charac-
teristic product of differentiating erythroid cells.
As we have previously noted (7, 8), benzidine-
positive colonies are limited in their proliferative
capacity. Sectored colonies (those exhibiting a
mixed phenotype) ariseifcells become committed
after plating in plasma culture (7). In the experi-
ments reported in this study, sectored colonies
were never found to represent more than 3% ofthe
total colonies observed in plasma culture. The
proportion of sectored colonies that occur under
a variety of experimental conditions is shown in
TABLE III
Effect of 0.5 hg/ml Cycloheximide on the
Proportion of Sectored Colonies
MEL cells were grown in liquid culture in the presence
of 1 .5% DMSO for 21 h. Thecellswere then subcultured
and growth continued in either 1.5% DMSO, or 1 .5%
DMSO plus 0.5 pg/ml of cycloheximide. At the times
indicated, an aliquot of cells was removed from each
culture and plated in plasma clots in the absence of
DMSO and cycloheximide for a period of 96 h. Cells
were harvestedas hasbeen described, and theproportion
of sectored colonies was determined at x 400 under oil
immersion. A minimum of 200 colonies was scored at
each time point.
Table III. It is clear from these results that cyclo-
heximide treatment does not lead to a significant
increase in the proportion of sectored colonies.
The effect of cycloheximide on the induction of
the development program of MEL cells with
DMSO has been examined by preexposing a cul-
ture to cycloheximide and comparing the kinetics
of commitment to differentiation of the drug-
treated cells with that of a control culture. The
results of such an experiment are shown in Fig. 2.
When a culture of MEL cells was treated with
either 5 jig/ml (panel A) or 0.5 ttg/ml (panel B) of
cycloheximide before induction with DMSO, no
delay in the appearance of committed cells was
observed after cycloheximide removal and subse-
quent treatment with 1.5% DMSO. These results
indicate that the effect of cycloheximide treatment
on commitment may be rapidly reversed after
removal of the inhibitor.
Is Protein Synthesis Necessary before the
Time of Commitment?
Underthe conditions used in these experiments,
treatment with DMSO must continue for a period
of at least nine h before a significant portion of
the population becomes committed to differentia-
tion.
To examine whether the commitment of MEL
cells to erythroid differentiation is dependent on
protein synthesis before the commitment event,
i.e., during the latent period, the following exper-
imental protocol was adopted: MEL cells were
seeded in liquid culture in the presence of 1.5%
DMSO plus 0.5 p,g/ml of cycloheximide and in-
cubated in thepresence of thedrug formost or all
ofthe latent period. Aftercycloheximide removal,
continued growth of the cultures was carried out
in the presence of 1.5% DMSO. Theaccumulation
of committed cells in the cycloheximide-treated
cultures was then compared to that of a control
culture that was exposed to 1.5% DMSO for the
entire course of the experiments.
The resultsoftwo separate experiments employ-
ing such a protocol are shown in Fig. 3. MEL
cultures were treated with 0.5 ttg/ml of cyclohex-
imide for either 9 h (panel A) or 12 h (panel B),
before removal of the drug and culture in DMSO
alone. In both experiments, the accumulation of
committed cells in the population was blocked
during the cycloheximide treatment period. In the
case of a 9-h exposure to the inhibitor (panel A),
the appearance of committed cells, as determined
by the percentage of benzidine-reactive colonies,
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FIGURE 2
￿
Effect ofapreexposure of cycloheximide on
the differentiation of MEL cells. I x 105 MEL cells/ml
were seeded in liquid culture in the presence (") or
absence (O) of cycloheximide for a period of 12 h. Cells
grown in thepresence ofcycloheximide were centrifuged
and resuspended in fresh culture medium lacking the
inhibitor. Both this culture and the culture which was
initially grown in the absence of cycloheximide were
adjusted to a cell density of 1 x 105/ml, then inducedto
differentiate by the addition of 1.5% DMSO. Panel A:
Preexposure to 5 lig/ml cycloheximide. Panel B: Preex-
posure to 0.5 wg/ml cycloheximide. An aliquot was
removed from the cultures at the times indicated, and
---200 cells from each culturewere plated in plasma clots
in theabsence of DMSO. Plasma cultures were harvested
96 h later, and the proportion of benzidine-reactive
colonies was determined as described in Materials and
Methods.
is delayed by --9 h subsequent to removal of
cycloheximide from theculture and treatmentwith
DMSO alone. After a l2-h inhibitor treatment
period (panel B), commitment of MEL cells to
differentiation was also delayed by -9 h.
These results support the view that commitment
of MEL cells to the program of erythroid differ-
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FIGURE 3
￿
Effect of commitment of MEL cells treated
with cycloheximide during the latent period. 1 x 105
cells/ml were seeded in liquid culturein thepresence of
1 .5% DMSO and 0.5 yg/ml of cycloheximide. Cultures
were exposedto the drug for either 9 h (panel A) or 12
h(panel B). Acontrolculture, seeded at 1 x 105cells/ml
and treated with 1.5% DMSO, was started in parallel
with each cycloheximide-treated culture. At either 9 h
(panel A) or 12 h (panel B), cultures were washed free
of the drug and resuspended in fresh media in the
presence of 1.5%DMSO. At the timesindicated, aliquots
were removed from the cultures and plated in plasma
clots as described. Commitment assays were then per-
formed in the manner outlined in Materials and Meth-
ods. Cultures grown continually in 1 .5% DMSO are
represented by the open circles, while cycloheximide-
treated cultures are indicated by the closed circles. The
arrows represent the time of removal of cycloheximide.
entiation does require aperiod of protein synthesis
before the commitment event itself.
Is Protein Synthesis Required Subsequent to
the Latent Period?
To examine the requirement for protein synthe-
sis at the time of commitment, we employed the
following experimental design: MEL cells were
treated with 1.5% DMSO fora period longer than
the latent period, then exposed to cycloheximide
for the remainder of theexperiment. If cyclohexi-
mide inhibits the commitment event itself, then
the proportion of committed cells in the popula-
tion should be significantly lower than that of a
control culture grown in the continuous presence
of 1.5% DMSO alone.
The results of such an experiment are shown in
Fig. 4. MEL cells were grown in liquid culture in
the presence of 1.5% DMSO for either 18 or 25 h.50
"I- 12 20
￿
30
Time (hours)
FIGURE 4
￿
Effect of cycloheximide on thecommitment
to differentiation of MEL cells. MEL cells were grown
in liquid culture in the presence of 1 .5% DMSO for
either 18 or 25 h. At the times indicated by the arrows,
the cells were subcultured and growth wascontinued in
thepresence of 1.5%DMSO alone("), or in thepresence
of 1.5% DMSO plus 0.5 hg/ml of cycloheximide (O,
O). At the times shown, a 1-ml aliquot of cells was
removed from each culture and treated as described in
the legend to Fig. 3.
At these times, the cells were subcultured and
growth continued in the presence of either 1.5%
DMSO or 1.5% DMSO plus 0.5 Ag/ml of cyclo-
heximide. As demonstrated in Fig. 4, it was ob-
served that commitment was blocked in both cy-
cloheximide-treated cultures. This and other sim-
ilarly designed experiments (datanot shown) sug-
gest that cycloheximide acts to block commitment
regardless of when the inhibitor is added subse-
quentto the end of thelatent period. Onepotential
difficulty in assessing the specificity of inhibitor
treatment on commitment is the possibility that
the block to commitment is due not to a specific
effect ofcycloheximide on commitment,but rather
to a general inhibition of cellular function unre-
lated to commitment. To show more directly that
cycloheximide specifically blocks commitment, we
have compared the averagesize of both committed
and uncommitted colonies in plasma clots after
cycloheximide treatment. Ifcycloheximide directly
blocks commitment, then the average size of both
committed and uncommitted colonies should be
equivalent to that of a control culture. If, on the
other hand, cycloheximide serves to inhibit cell
metabolism in general, and commitment indi-
rectly, then the average size of committed and
uncommitted colonies in a drug-treated culture
might be expected to be significantly smaller than
in an untreated control culture. As shown in Fig.
5, the average size ofboth committed anduncom-
mitted colonies in a cycloheximide-treated culture
and untreated control culture was found to be
identical. In this experiment, we have compared
the average size of uncommitted colonies in a
culturetreated for 19 h with 1.5% DMSO,then for
8 h with 1.5% DMSO plus 0.5 p,g/ml cyclohexi-
mide (panel B), with that in a control culture
treated for 27 h with 1.5% DMSO (panel A). The
average cell number of benzidine-negative colo-
nies in both cultures was found to be essentially
equivalent. We have also compared the size of
committed colonies (panel D) in the culture
treated with cycloheximide (as described in panel
B) with that in a control culture treated for 19 h
with 1.5%DMSO (panel C). Ifcycloheximide does
in fact specifically block commitment, then the
average size of benzidine-positive colonies in a
cycloheximide-treated culture should be the same
as the average size of benzidine-positive colonies
in aculturetreated with inducer up to thepoint at
which inhibitor is added. This point is verified by
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FIGURE 5 Effect of cycloheximide treatment on the
size of uncommitted and committedcolonies. MELcells
were grown in liquid culture in the presence of 1 .5%
DMSO for 19 h. The cells were then subcultured and
growth continued in the presence of 1 .5% DMSO alone
(panels A and C) or in the presence of 1.5% DMSO +
0.5 pg/mlofcycloheximide (panelsB and D).At 19 and
27 h, an aliquot was removed from each culture and
plated in plasma clots in the absence of DMSO and
cycloheximide for96 h, afterwhichcellswere harvested,
fixed, andstainedas hasbeen described. Thesize ofpure
red or pure blue colonies was then determined at x 400
under oil immersion. A minimum of 200 colonies was
scored foreach time point. Panels A, B, andDrepresent
colony size distribution at 27 h after the start of the
experiment. Panel C represents a culture treated with
1.5% DMSO for 19 h.
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A No Cycloheximide C No Cycloheximide
B Dthe results shownin panels C and D. These results
are consistent with the view that the block to
commitment exerted by cycloheximide treatment
is the result of a direct action of the drug on
cellular reprogramming and is not the result of a
more general cytotoxic effect of cycloheximide
treatment which leads indirectly to the inhibition
of commitment.
Varying the dose of cycloheximide has a signif-
icant effect on the commitment of MEL cells to
erythroid differentiation. A culture was treated
with 1.5% DMSO for 21 h, then divided into
several subcultures that were either maintained in
1.5% DMSO or treated with 1.5% DMSO plus a
dose of cycloheximide ranging in concentration
from 5 p.g/ml to 0.005 lig/ml. As shown in Fig. 6,
the increase in the proportion of committed cells
in the cultures treated with either 5 [tg/ml or 0.5
pg/ml of cycloheximide was rapidly blocked after
treatment with thedrug, whereasa culturetreated
with 0.05 jig/ml cycloheximide showed an inter-
mediatelevelof inhibition. MEL cellstreated with
0.005 pg/ml of cycloheximide, however, exhibited
kinetics of accumulation of committed cells which
very nearly approximate that of a control culture,
while cells treated with 0.0005 p.g/ml cyclohexi-
mide (data not shown) were indistinguishable
from the control culture.
Does Another Protein Synthesis Inhibitor also
Block Commitment?
The block to commitment which results from
exposure of MEL cells to cycloheximide may be
due to a direct effect of the drug on protein
synthesis or, alternatively, may be due to a side
effect of the drug. One approach to this problem
is to employ inhibitors of protein synthesis that
operate via othermechanisms such as puromycin.
Puromycin causes premature termination of poly-
peptide chains (15), whereas cycloheximide pre-
vents the formation of peptide bonds (16). The
results of an experiment with use of puromycin
arepresented in Fig. 7. Aculture of MELcellswas
treated with 1.5% DMSO for 19 h, then subcul-
tured and grown in 1.5% DMSO plus either 0.5
pg/ml cycloheximide or 1 p,g/ml of puromycin.
These cultures behaved alike with respect to the
inhibition of commitment after administration of
the drugs. In both cases, the increase in the pro-
portion of committed cells was rapidly inhibited.
A culture treated with 0.1 p.g/ml of puromycin, on
the other hand, showed an intermediate level of
commitment when compared to a control culture.
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FIGURE 6 Effect of cycloheximide concentration on
the commitment to differentiation ofMELcells. l x 105
MEL cells/ml were seeded in liquid culture in thepres-
ence of 1 .5% DMSO. Cellswere grownin inducer for 21
h.The culturewas divided and growth continuedin the
presence of inducer ("). Cycloheximide was added to
parallel cultures at either 5 Ag/ml (O), 0.5 pg/ml (W,
0.05 pg/ml P, or 0.005 pg/ml (A). One culture was
removed from DMSO and transferred to fresh media
(p). At various times, 1-ml aliquots were removed from
each of the cultures, centrifuged, and resuspended in
fresh media at 2 x 10" cells/ml. Approx. 200 cells from
each culturewere plated in plasma clots in theabsence
of DMSO and cycloheximide for 96 h, afterwhichcells
were harvested, fixed, stained, and the proportion of
committedcells from each culturewasdetermined as has
been described.
Kinetics ofAppearance of Committed Cells
The results shown in Fig. 2 and Tables I and II
indicate that the effects of cycloheximide on MEL
cellsare rapidlyreversed afterremovalofthe drug.
We therefore wished to examine the effect of
cycloheximide treatment on the kinetics of reap-
pearance ofcommittedcellsaftera pulse exposure
of MEL cells to cycloheximide subsequent to the
latent period. Results of such an experiment are
shown in Fig. 8. The increase in theproportion of
committed cells in a culture grown in the presence
of 1.5% DMSO for22 h was quickly blocked after
treatment with 0.5 pg/ml of cycloheximide. After
a 6-hpulse exposure to cycloheximide, removalof
the drug, and culture in DMSO alone, an imme-
diate increase in the proportion ofcommitted cells
was observed. No significant lag in the rate of
increase in number of committed cells was de-
tected. When the cycloheximide-treated culture
was normalized in time (by plotting all points 6 h
earlier to account for the cycloheximide pulse
period) to the control, the two curves are indistin-a
20
Time (hours)
015 % DAASO
0.1 /'Q1'1
Puromycin
5 ug/ml Cyclo.
Puromycin
FIGURE 7
￿
Effect of puromycin and cycloheximide on
thecommitment to differentiationof MEL cells. l x 105
MEL cells/ml were grown in the presence of 1 .5%
DMSO for 19 h. The culture was then divided into five
subcultures which were treated as follows: A control
culture (O) was allowed to continue growth in the pres-
ence of 1.5% DMSO, while a second culture (") was
removed from DMSO and grown in fresh media. Of the
remaining cultures, all were grown in the presence of
1 .5% DMSO, but to one was added puromycinat I ug/
ml (/), to a second, puromycin at 0.1 hg/ml (0), and to
a third, 0.5 Irg///ml of cycloheximide (A). At the times
indicated, a 1-ml aliquotwasremoved from each culture,
centrifuged, and resuspended in fresh media at adensity
of 2 x l0° cells/ml. Approx. 200 cells were plated in
plasma culturein theabsence of allagents for 96 h. Cells
were then harvested onto microscope slides, fixed,
stained, and the proportion of committed cells was de-
termined as previously described.
guishable (see inset to Fig. 8). MEL cells exposed
to cycloheximide for a 6-h period after a 22-h
induction in the presence of 1 .5% DMSO thus
appear to be capable of an immediate resumption
of the developmental program once the block to
protein synthesis has been removed.
DISCUSSION
The inhibition of both protein synthesis and com-
mitment resulting from treatment with cyclohexi-
mide is rapidly reversed after removal of MEL
cells from the inhibitor. Thereversibilityof cyclo-
heximide-mediated effects has permitted the use
of the drug to assess the requirement for protein
synthesis for the maintenance of the program of
differentiationof MEL cells. The abilityto achieve
closeto 100% platingefficiency in all experimental
situations has provided a reliable and accurate
means to determine the effect of inhibitor treat-
ment on all cells in the population.
The resumption of the developmental program
of MEL cells occurs immediately after removal of
cycloheximide. The duration of the block in the
program appears to be equivalent in length to the
inhibitor treatment period. When MEL cells are
treated with DMSO and cycloheximide for a pe-
riod of time equal to or greater than the length of
the latent period, no progress through the latent
period is observed. MEL cells treated in this way
behave like cells unexposed to DMSO. Commit-
ment is initiated in such cultures -9 h after re-
moval of cycloheximide.
The administration of cycloheximide to DMSO-
treated MEL cells in a pulse-chase type protocol
indicates that the rate-limiting step in the differ-
entiation program is not the build-up of one or
more proteins with a relatively short half-life. No
delay in the kinetics ofcommitment to differentia-
tion is observed after removal of cycloheximide
after a6-h pulseand subsequent growth in DMSO
alone. This observation is consistent with the con-
DMSO
"
I
MS.-
05pg/.ICYCL0 .15% rMS0
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￿
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40
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FIGURE 8
￿
Kinetics of appearance of committed cells
after a pulsewith cycloheximide. l x 105 MEL cells/ml
were seeded in liquid culture in the presence of 1.5%
DMSO and grown in the presence of inducer for 22 h.
Theculture was then divided into three subcultures and
growth was continued either in the presence of 1.5%
DMSO (O), 1.5% DMSO plus 0.5 tLg/ml cycloheximide
("), or in the absence of DMSO and cycloheximide (O)
foran additional bh. Thecontrolculturewasmaintained
in 1.5% DMSO, whereas the culture treated with cyclo-
heximide (")wasremovedfrom thepresence of inhibitor
and growth then continued in the presence of 1.5%
DMSO. The culture grown in media without additions
during the 6-h pulse period was then made 1.5% by the
addition of DMSO (Q). At the time indicated, aliquots
were takenfrom each culture, and--200cells were plated
in plasma culture in the absence of DMSO and cyclo-
heximide. Cultures were harvested at -96 h, and the
proportion of committed cells was determined as has
been described. Theinset represents a plot ofthe control
culture (O)growncontinuously in 1.5% DMSO and the
culture pulsed for 6 h with 0.5 tLg/ml cycloheximide
(")where the " time points forthecycloheximide-treated
culture have been normalized in time to the control (by
shifting the points 6 htowards the origin).
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critical for the differentiation program, decays
with a half-life of <6 h.
A study of the proteins synthesized by induced
and uninduced MEL cells has revealed no signif-
icant pattern differences when compared on two-
dimensional polyacrylamide gels (17). Several new
species of proteins were detected in the nucleus,
though it is possible that these proteins play no
part in the reprogramming of cellular function.
One interpretation of these results is that protein
synthesis is not a requirement for some steps in
the differentiation of MEL cells. The results pre-
sented in this manuscript strongly suggest, how-
ever, that continuous protein synthesis is required
during the course of the differentiation program.
Whetherqualitatively newsets of proteins must be
synthesized for commitment to occur cannot be
determined from thecurrent series of experiments.
The relationship between DNA synthesis and
differentiation in MEL cells has been investigated
in several studies (5, 10, 12). Although these ex-
periments suggested a potential relationship be-
tween differentiation and DNA synthesis, it is
difficult to assess the requirement for DNA repli-
cation forcommitment, since thesestudies did not
focus on the early biochemical changes which
occur after induction. The data of Leder et al. (9),
on the other hand, argue against a direct relation-
ship between DNA synthesis and the differentia-
tion program in MEL cells. In a study to be
reported elsewhere (Levenson et al., manuscript
submitted for publication), we have focused di-
rectly on the relationship between DNA synthesis
and the commitment to differentiation of MEL
cells. We have found that inhibition of DNA
replication does not block the commitment proc-
ess. This finding supports the idea that the block
to commitment resulting from treatment of MEL
cells with cycloheximide is due to the specific
inhibition of a component critical for the repro-
gramming of MEL cells which is independent of
DNA synthesis. Similar results have recently been
reported by Nadal-Ginard (14) who found that
thecommitment ofmyoblaststo the differentiation
program occurs in the absence of DNA synthesis.
Thepotentialeffects ofcycloheximide treatment
on RNA metabolism in cultured MEL cells have
notbeen directly examined in the studies reported
here. Willems et al. (23) and Craig and Perry (3)
have studied the effects of cycloheximide treat-
ment on RNA synthesis. Both studies showed that
cycloheximide affects RNA synthesisindirectly by
724
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME 82, 1979
reducing the rate of processing ofribosomal RNA
at concentrations of 50 pg/ml of cycloheximide. It
has also been reported by Ross et al. (20) that
globin mRNA accumulation in MEL cells is in-
hibited by cycloheximide treatment. The signifi-
canceof this observation is obscured, however, by
the fact that neither commitment nor the terminal
differentiation status of these cycloheximide-
treated cells was determined. It clearly will be of
interest to examine the requirement for RNA,
particularly mRNA synthesis, for the commitment
of MEL cells.
The results of experiments carried out in a
varietyof other systems also support the view that
the initiation ofa developmental programexhibits
a requirement for protein synthesis. The commit-
ment of yeast (21) and 3T3 cells (2) forentry into
the cell division cycleis sensitive to cycloheximide
treatment and appears to involve the synthesis of
a protein component with a relatively short half-
life. In addition, the concanavalin-A induced
transformation of cultured lymphocytes is sensi-
tive to the inhibition of protein synthesis but does
not appear to require concomitant DNA replica-
tion (13).
We have shown in this study that the inhibition
of protein synthesis in cultured MEL cells, both
before and at the time of commitment, blocks the
expression of the differentiation program. The
high plating efficiencies obtained throughout these
studies rule out the possibility that the block to
differentiationthat we observe is dueto acytotoxic
effect of the inhibitors employed. The fact that
both puromycin and cycloheximide, two protein
synthesis inhibitors with different mechanisms of
action, affect commitment in a similar fashion
supports the idea that protein synthesis is a nec-
essary component of the early differentiation pro-
gram and that the drug-induced block is not the
result of a specific side effect of the drug itself.
Our understanding of the biochemical and mo-
lecular events underlying the control of develop-
mental programs will depend on our ability to
dissect the various components involved in such
programs. The basic approach outlined in this
paper can be applied in a variety of situations to
identify the requirement for specific macromolec-
ular events involved in the reprogramming of cel-
lular function.
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